To determine whether the tumor tissues had increased levels of RS or DNA damage when the mice were treated with IBC and BKC, we used immunohistochemistry to monitor cell proliferation (staining for Ki67) and checkpoint activation (staining for CHK1/CHK2 phosphorylation) and the TUNEL fluorescence assay for DNA fragmentation. Here, CHEK2 is linked to neoplasm.